|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | ESPEN guidelines on parenteral nutrition: geriatrics 显示文摘 | Sobotka L Schneider SM Berner YN etaJ | 2009 | Clin Nutr2009，28，4： | 1 |
| 2 | Complications in patients undergo- ing pulmonary oncological surgery 显示文摘 | Mitos L Horvath T Sobotka M | 2010 | Rozhl Chit2010，89，2： | 1 |
| 3 | Catheter-based renal denervation for resistant hypertension: rationale and design of the Symplicity HTN-3 trial显示文摘 | KANDZARI D E BHATT D L SOBOTKA P A | 2012 | Clin Cardiol2012，35，9： | 1 |
| 4 | Force characteristics of the rat sternomastoid muscle reinnervated with end-to-end nerve repair显示文摘 | Sobotka S Mu L | | 0，，： | 1 |
| 5 | The pathophysiology underlying the obesity paradox显示文摘 | Soeters PB Sobotka L | 2012 | Nutrition2012，28，6： | 1 |
| 6 | Zucker diabetic fatty rat:a new model of impaired cutaneous wound repair with type II diabetes mellitus and obesity显示文摘 | Slavkovsky R Kohlerova R Tkacova V Jiroutova A Tahmazoglu B Velebny V Reza?ováM Sobotka L Kanta J | 2011 | Wound Repair Regen2011，19，4： | 1 |
| 7 | ESPEN Guide- lines on Parenteral Nutrition: geriatrics 显示文摘 | Sobotka L Schneider SM Berner YN | 2009 | Clin Nutr2009，28，4： | 1 |
| 8 | Demographic and medical consequences of the postponement of parenthood显示文摘 | Schmidt L Sobotka T Bentzen JG Nyboe Andersen A ESHRE Reproduction and Society Task Force | 2012 | Hum Reprod Update2012，18，1： | 1 |
| 9 | Demographic and medical consequences of the postponement of parenthood显示文摘 | Schmidt L Sobotka T Bentzen J G | 2012 | Hum Reprod update2012，18，1： | 1 |
| 10 | ESPEN guidelines on parenteral nutrition显示文摘 | Sobotka L Schneider SM Berner YN | | 0，，04： | 1 |
| 11 | Parenteral nutrition in catabolic states using Neonutrin 5%,a new amino solution显示文摘 | ZADAK Z SOBOTKA L | 2002 | Vnitr Lek2002，48，： | 1 |
| 12 | Rare cause of dysphagia after esophageal variceal banding: A case report显示文摘BACKGROUND Esophageal varices are a result of progressive liver disease and portal hypertension. Treatment can be performed with band ligation versus nonselective beta blockers depending on the size of varices, ability to tolerate medications and history of variceal bleeding. Band ligation is an effective intervention with rare but serious complications including bleeding, ulcers and rarely obstruction. Few cases of esophageal obstruction and necrosis caused by banding have been reported, each with varied management from conservative treatment to band removal.CASE SUMMARY An 89 years old woman with a past medical history of nonalcoholic steatohepatitis cirrhosis presented to the hospital with an inability to swallow one day after screening esophagogastroduodenoscopy where band ligation of esophageal varices was performed for primary prophylaxis. The patient was not able to tolerate her oral secretions. Initial blood work revealed a Model of End Organ Liver Disease score of 7. She was treated with sublingual nitroglycerin for esophageal spasm, a known complication after esophageal banding. When she failed to improve, esophagogastroduodenoscopy was performed and revealed the mucosa surrounding the banded varix was necrosed and blocking the lumen of the esophagus. The band was purposefully dislodged, revealing distal ulceration and stricturing. Within 72 h after band removal, she was tolerating an oral diet. Endoscopy performed 2 wk later revealed an intrinsic stenosis,measuring 8 mm in diameter by 1 cm in length, which was dilated.CONCLUSION Esophageal obstruction is a complication of variceal banding that should be considered in patients with inability to tolerate oral diet after banding. | Lindsay A Sobotka Mitchell L Ramsey Michael Wellner Sean G Kelly | 2019 | World Journal of Gastrointestinal Endoscopy2019，11，4： | 1 |
| 13 | Specific nutritional support accelerates pressure ulcer healing and reduces wound care intensity in non-malnourished patients显示文摘 | van Anholt RD Sobotka L Meijer EP | 2010 | Nutrition2010，26，8： | 1 |
| 14 | Specific nutritional supportaccelerates pressure ulcer healing and reduces wound care intensity innon - malnourished patients显示文摘 | Anholt RD Sobotka L Meijer EP | 2010 | Nutrition2010，26，9： | 1 |
| 15 | Catheter- based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN - 3 Trial 显示文摘 | KANDZARI D E BHATT D L SOBOTKA P A | 2012 | Clin Cardiol2012，35，9： | 1 |
| 16 | ESPEN guidelines on parenteral nutrition:geriatrics显示文摘 | Sobotka L Schneider S Berner Y | 2009 | Clin Nutr2009，28，4： | 1 |
| 17 | ESPEN Guide- lines on parenteral nutrition: geriatrics显示文摘 | Sobotka L Schneider S M Berner Y N etal | 2009 | Clin Nutr2009，28，4： | 1 |
| 18 | Specific nutritional sup port accelerates pressure ulcer healing and reduces wound care intensity in non- malnourished patients显示文摘 | Anholt RD Sobotka L Meiier EP | 2010 | Nutrition2010，26，9： | 1 |
| 19 | Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis显示文摘BACKGROUND Cystic fibrosis transmembrane conductance regulator(CFTR)modulators significantly improve pulmonary function in patients with cystic fibrosis(CF)but the effect on hepatobiliary outcomes remains unknown.We hypothesized that CF patients on CFTR modulators would have a decreased incidence of cirrhosis compared to patients not on CFTR modulators or on ursodiol.AIM To investigate the effect of CFTR modulators on the development of cirrhosis in patients with CF.METHODS A retrospective analysis was performed using Truven MarketScan from January 2012 through December 2017 including all patients with a diagnosis of CF.Patients were excluded if they underwent a liver transplantation or if they had other etiologies of liver disease including viral hepatitis or alcohol use.Subjects were grouped by use of CFTR modulators,ursodiol,dual therapy,or no therapy.The primary outcome was development of cirrhosis.Kaplan-Meier curves estimated the incidence of cirrhosis and log-rank tests compared incidence curves between treatment groups.RESULTS A total of 7201 patients were included,of which 955(12.6%)used a CFTR modulator,529(7.0%)used ursodiol,105(1.4%)used combination therapy,and 5612(74.3%)used neither therapy.The incidence of cirrhosis was 0.1%at 1 year and 0.7%at 4 years in untreated patients,5.9%and 10.1%in the Ursodiol group,and 1.0%and 1.0%in patients who received both therapies.No patient treated with CFTR modulators alone developed cirrhosis.Patients on CFTR modulators alone had lower cirrhosis incidence than untreated patients(P=0.05),patients on Ursodiol(P<0.001),and patients on dual therapy(P=0.003).The highest incidence of cirrhosis was found among patients treated with Ursodiol alone,compared to untreated patients(P<0.001)or patients on Ursodiol and CFTR modulators(P=0.01).CONCLUSION CFTR modulators are associated with a reduction in the incidence of cirrhosis compared to other therapies in patients with CF. | Mitchell L Ramsey Michael R Wellner Kyle Porter Stephen E Kirkby Susan S Li Luis F Lara Sean G Kelly A James Hanje Lindsay A Sobotka | 2022 | World Journal of Hepatology2022，14，2： | 0 |
| 20 | Outcomes of inpatient cholecystectomy among adults with cystic fibrosis in the United States显示文摘BACKGROUND Symptomatic biliary and gallbladder disorders are common in adults with cystic fibrosis(CF)and the prevalence may rise with increasing CF transmembrane conductance regulator modulator use.Cholecystectomy may be considered,but the outcomes of cholecystectomy are not well described among modern patients with CF.AIM To determine the risk profile of inpatient cholecystectomy in patients with CF.METHODS The Nationwide Inpatient Sample was queried from 2002 until 2014 to investigate outcomes of cholecystectomy among hospitalized adults with CF compared to controls without CF.A propensity weighted sample was selected that closely matched patient demographics,patient’s individual comorbidities,and hospital characteristics.The propensity weighted sample was used to compare outcomes among patients who underwent laparoscopic cholecystectomy.Hospital outcomes of open and laparoscopic cholecystectomy were compared among adults with CF.RESULTS A total of 1239 inpatient cholecystectomies were performed in patients with CF,of which 78.6%were performed laparoscopically.Mortality was<0.81%,similar to those without CF(P=0.719).In the propensity weighted analysis of laparoscopic cholecystectomy,there was no difference in mortality,or pulmonary or surgical complications between patients with CF and controls.After adjusting for significant covariates among patients with CF,open cholecystectomy was independently associated with a 4.8 d longer length of stay(P=0.018)and an$18449 increase in hospital costs(P=0.005)compared to laparoscopic cholecystectomy.CONCLUSION Patients with CF have a very low mortality after cholecystectomy that is similar to the general population.Among patients with CF,laparoscopic approach reduces resource utilization and minimizes post-operative complications. | Mitchell L Ramsey Lindsay A Sobotka Somashekar G Krishna Alice Hinton Stephen E Kirkby Susan S Li Michael P Meara Darwin L Conwell Peter P Stanich | 2021 | World Journal of Gastrointestinal Endoscopy2021，13，9： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员